Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. ACN
4. IONS
5. AZN
6. ROIV
7. AAPL
8. NVDA
9. USO
10. ORCL

Go back to Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
(NASDAQ: ALLR) Delayed: 1.33 -0.09 (6.34%)
Previous Close $1.42    52 Week High $ 
Open $1.36    52 Week Low $ 
Day High $1.37    P/E N/A 
Day Low $1.31    EPS $ 
Volume 105,826       

(NASDAQ: ALLR) Delayed: 1.33 -0.09 (6.34%)
Previous Close $1.42    52 Week High $ 
Open $1.36    52 Week Low $ 
Day High $1.37    P/E N/A 
Day Low $1.31    EPS $ 
Volume 105,826